Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for Antipsychotic-Induced Hyperprolactinemia
NCT00975611Phase 4Terminated
- Start
- Oct 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amantadine in hyperprolactinemia (3 arms). Primary endpoint: Change in Prolactin Levels for Individuals Treated With Adjunctive Amantadine Versus Placebo at 8 weeks. Started Oct 2009; status: terminated.
02
Drugs
amantadine
03
Conditions
hyperprolactinemia
Beyond the preview
Go deeper on NCT00975611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975611.